Conformational features of a synthetic-cyclic peptide corresponding to the complete V3 loop of the RF HIV-1 strain in water and water/trifluoroethanol solutions

European Journal of Biochemistry

Volumn 236, Issue 1, 1996, Pages 100-108

  Vranken, W F ^a   Budesinsky, M ^a   Martins, J C ^a   Fant, F ^a   Boulez, K ^a   Gras Masse, H ^a   Borremans, F A M ^a  

^a Department Organic Chemistry   (Belgium)

Author keywords

Amphipathic helix; CD; Human immunodeficiency virus type 1 (HIV 1); NMR; RF V3 loop

Indexed keywords

CYCLOPEPTIDE; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; SYNTHETIC PEPTIDE;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN SYNTHESIS; X RAY ANALYSIS;

EID: 0029670024     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.00100.x     Document Type: Article

References (45)

1. 1 Capon, D. J. & Ward, R. H. R. (1991) The CD4‐gp120 interaction and AIDS pathogenesis, Annu. Rev. Immunol. 9, 649–678.
2. 2 McKeating, J. A., Cordell, J., Dean, C. J. & Balfe, P. (1992) Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120, Virology 191, 732–742.
3. 3 Moore, J. P., McKeating, J. A., Weiss, R. A. & Sattentau, Q. J. (1990) Dissociation of gp120 from HIV‐1 virions induced by soluble CD4, Science 250, 1139–1142.
4. 4 Stein, B. S., Gowda, S. D., Lifson, J. D., Penhallow, R. C., Bensch, K. G. & Engelman, E. G. (1987) pH‐independent HIV entry into CD4‐positive T cells via virus envelope fusion to the plasma membrane, Cell 49, 659–668.
5. 5 Freed, E. O., Meyers, D. J. & Risser, R. (1991) Identification of the principle neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain, J. Virol. 65, 190–194.
6. 6 Leonard, C. K., Spellman, M. S., Riddle, L., Harris, R. H., Thomas, J. N. & Gregory, T. J. (1990) Assignment of intrachain disulphide bonds and characterization of potential glycosylation sites of the type I recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells, J. Biol. Chem. 265, 10373–10382.
7. 7 Skinner, M. A., Langlois, A. J., McDanal, C. B., McDougal, J. S., Bolognesi, D. P. & Matthews, T. J. (1988) Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4, J. Virol. 62, 4195–4200.
8. 8 Johnson, M. E., Lin, Z., Padmanabhan, K., Tulinsky, A. & Kahn, M. (1994) Conformational rearrangements required of the V3 loop of HIV‐1 gp120 for proteolytic cleavage and infection, FEBS Lett. 337, 4–8.
9. 9 Hattori, T., Koito, A., Takatsuki, K., Kido, H. & Katunuma, N. (1989) Involvement of tryptase‐related cellular protease(s) in human immunodeficiency virus type 1 infection, FEBS Lett. 248, 48–52.
10. 10 Nehete, P. N., Arlinghaus, R. B. & Sastry, K. J. (1993) Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120, J. Virol. 67, 6841–6846.
11. 11 Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., Putney, S. D. & Matthews, T. J. (1989) Principle neutralizing domain of the human immunodeficiency virus type 1 envelope protein, Proc. Natl Acad. Sci. USA 86, 6768–6772.
12. 12 LaRosa, G. J., Davide, J. P., Weinhold, K., Waterbury, J. A., Profy, A. T., Lewis, J. A., Langlois, A. J., Dreesman, G. R., Boswell, R. N., Shadduck, P., Hofley, L. H., Karplus, M., Bolognesi, D. P., Matthews, T. J., Emini, E. J. & Putney, S. D. (1990) Conserved sequence and structural elements in the HIV‐1 principal neutralizing determinant, Science 249, 932–935.
13. 13 Javaherian, K., Langlois, A. J., LaRosa, G. J., Profy, A. T., Bolognesi, D. P., Herlihy, W. C., Putney, S. D. & Matthews, T. J. (1990) Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV‐1, Science 250, 1590–1593.
14. 14 Shioda, T., Levy, J. A. & Cheng‐Mayer, C. (1992) Small amino acid changes in the V3 hypervariable region of gp120 can affect the T‐cell‐line and macrophage tropism of human immunodeficiency virus type 1, Proc. Natl Acad. Sci. USA 89, 9434–9438.
15. 15 Korber, B. T. M., Farber, R. M., Wolpert, D. H. & Lapedes, A. S. (1993) Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: An information theoretic analysis, Proc. Natl Acad. Sci. USA 90, 7176–7180.
16. 16 Milich, L., Margolin, B. & Swanstrom, R. (1993) V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability, J. Virol. 67, 5623–5634.
17. 17 Chandrasekar, K., Profy, A. T. & Dyson, H. J. (1991) Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV‐1 envelope glycoprotein gp120, Biochemistry 30, 9187–9194.
18. 18 Catasti, P., Fonteno, J. D., Bradbury, E. M. & Gupta, G. (1995) Local and global structural properties of the HIV‐MN V3 loop, J. Biol. Chem. 270, 2224–2232.
19. 19 Gupta, G., Anantharamaiah, G. M., Scott, D. R., Eldridge, J. H. & Myers, G. (1993) Solution structure of the V3 loop of a Thailand HIV isolate, J. Biomol. Struct. & Dynam. 11, 345–366.
20. 20 Kumar, A., Wagner, G., Ernst, R. R. & Wüthrich, K. (1980) Studies of J ‐connectivities and selective 1 H‐ 1 H Overhauser effects in H 2 O solutions of biological macromolecules by two‐dimensional NMR experiments, Biochem. Biophys. Res. Commun. 96, 1156–1163.
21. 21 Bax, A. & Davis, D. G. (1985) MLEV‐17 based 2D homonuclear magnetization transfer spectroscopy, J. Magn. Reson. 65, 355–360.
22. 22 Bodenhausen, G., Kogler, H. & Ernst, R. R. (1984) Selection of coherence transfer pathways in NMR pulse experiments, J. Magn. Reson. 58, 370–388.
23. 23 Rance, M., Chazin, W. J. & Wright, P. E. (1989) Multiple‐quantum nuclear magnetic resonance, Methods Enzymol. 176, 114–134.
24. 24 Santoro, J., Bruix, M., González, C., Nieto, J. L. & Rico, M. (1992) Constant‐time NOESY: An aid in the analysis of protein NMR spectra, J. Biomol. NMR 2, 647–653.
25. 25 Wider, G., Hosur, R. V. & Wüthrich, K. (1983) Suppression of the solvent resonance in 2D NMR spectra of proteins in H 2 O solution, J. Magn. Reson. 52, 130–135.
26. 26 Marion, D. & Wüthrich, K. (1983) Application of phase sensitive 2D correlated spectroscopy (COSY) for measurements of 1 H‐ 1 H spin‐spin coupling constants in proteins, Biochem. Biophys. Res. Commun. 113, 967–974.
27. 27 Klevit, R. E. (1985) Improving 2D NMR spectra by t 1 ridge subtraction, J. Magn. Reson. 62, 551–555.
28. 28 Neidig, K.‐P. & Kalbitzer, H. R. (1990) Improved representation of two‐dimensional NMR spectra by local rescaling, J. Magn. Reson. 88, 155–160.
29. 29 Kjaer, M., Andersen, K. V. & Poulsen, F. M. (1994) Automated and semiautomated analysis of homo‐ and heteronuclear multidimensional nuclear magnetic resonance spectra of proteins: The program PRONTO, Methods Enzymol. 29, 288–318.
30. 30 Adler, A. J., Greenfield, N. J. & Fasman, G. D. (1973) Circular dichroism and optical rotatory dispersion of proteins and polypeptides, Methods Enzymol. 27, 675–735.
31. 31 Morrisett, J. D., Jackson, R. L. & Gotto, A. M. Jr (1977) Lipid protein interactions in the plasma lipoproteins, Biochim. Biophys. Acta 472, 93–133.
32. 32 Compton, L. A. & Johnson, W. C. Jr (1986) Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication, Anal. Biochem. 155, 155–167.
33. 33 Manavalen, P. & Johnson, W. C. Jr (1985) Protein secondary structure from circular dichroism spectra, Proc. Int. Symp. Biomol. Struct. Intr., J. Biosci. Suppl. 8, 141–149.
34. 34 Wüthrich, K. (1986) NMR of proteins and nucleic acids, John Wiley, New York.
35. 35 Merutka, G., Dyson, H. J. & Wright, P. E. (1995) Random coil 1 H chemical shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG, J. Biomol. NMR 5, 14–24.
36. 36 Wishart, D. S., Sykes, B. D. & Richards, F. M. (1991) Relationship between NMR chemical shift and protein secondary structure, J. Mol. Biol. 222, 311–333.
37. 37 Dyson, H. J., Rance, M., Houghten, R. A., Wright, P. E. & Lerner, R. A. (1988) Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix, J. Mol. Biol. 201, 201–217.
38. 38 Vranken, W. F., Budesinsky, M., Fant, F., Boulez, K. & Borremans, F. A. M. (1995) The complete consensus V3 loop peptide of the envelope protein gp120 of HIV‐1 shows pronounced helical character in solution, FEBS Lett. 374, 117–121.
39. 39 Tolman, R. L., Bednarek, M. A., Johnson, B. A., Leanza, W. J., Marburg, S., Underwood, D. J., Emini, E. A. & Conley, A. J. (1993) Cyclic V3‐loop‐related HIV‐1 conjugate vaccines. Synthesis, conformation and immunological properties, Int. J. Peptide Protein Res. 41, 455–466.
40. 40 de Lorimier, R., Moody, M. A., Haynes, B. F. & Spicer, L. D. (1994) NMR derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus, Biochemistry 33, 2055–2062.
41. 41 Zvi, A., Hiller, R. & Anglister, J. (1992) Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV‐1 IIIB: A two‐dimensional NMR study, Biochemistry 31, 6972–6979.
42. 42 Ghiara, J. B., Stura, E. A., Stanfield, R. L., Profy, A. T. & Wilson, I. A. (1994) Crystal structure of the principal neutralizing site of HIV‐1, Science 264, 82–85.
43. 43 Eisenberg, D., Weiss, R. M. & Terwilliger, T. C. (1982) The helical hydrophobic moment: a measure of the amphiphilicity of a helix, Nature 299, 371–374.
44. 44 Crofts, A. R. (1992) pSAAM for Windows, A. program for protein sequence analysis and modeling. Program runs under Windows 3. Copyright, University of Illinois, 1992. Shareware, available from anonymous ftp at http://nemo.life.uiuc.edu.
45. 45 Eisenberg, D., Schwarz, E., Komaromy, M. & Wall, R. (1984) Analysis of membrane and surface protein sequences with the hydrophobic moment plot, J. Mol. Biol. 179, 125–142.